Lack of evidence raises questions on long-term PPI use

There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...

PSA National President opening address at PSA24

Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).

New opioid patient resource

The balance between adequate pain relief and safety with opioids is now more achievable with the release of a handy new resource for patients...

Making carers visible in healthcare

Carers are frontline healthcare partners. Here's how pharmacists can recognise and empower them to transform patient care.

Depression and complementary medicines

Around one in 16 Australians will suffer from depression at some time during their life.1,2 What evidence is there that complementary medicines such as S-Adenosyl-L-methionine...

Medicine misadventure is common, reveals PSA

The Pharmaceutical Society of Australia (PSA) has released a new report, Medicine Safety: Take Care, which highlights the extent of the unsafe use of...